Key Findings:  Cannabidiol (CBD) appears to restore cognition in multiple studies of impairment, further investigation into its efficacy in schizophrenia.
Type of Study:  Meta-analysis
Study Sample Size:  27
Study Result:  Positive
Research Location(s):  Australia
Year of Pub:  2017
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III
Citation:  Osborne AL, et al. A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. Neurosci Biobehav Rev. 2017; 72:310-324. doi: 10.1016/j.neubiorev.2016.11.012
Authors:  Osborne AL, Solowij N, Weston-Green K